We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Consumer Discretionary 9.92%
3 Healthcare 7.34%
4 Financials 7.06%
5 Communication Services 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
4776
CALL
Automatic Data Processing
ADP
$112B
-24,500
Closed -$4.87M
ADT icon
4777
ADT
ADT
$5.42B
-23,915
Closed -$258K
AER icon
4778
PUT
AerCap
AER
$23.2B
-30,900
Closed -$1.58M
AFL icon
4779
CALL
Aflac
AFL
$59.3B
-61,300
Closed -$3.29M
AKYA
4780
DELISTED
Akoya BioSciences
AKYA
-14,309
Closed -$277K
ALG icon
4781
Alamo Group
ALG
$2.01B
-1,434
Closed -$219K
ALNY icon
4782
CALL
Alnylam Pharmaceuticals
ALNY
$31.6B
-21,000
Closed -$3.56M
ALV icon
4783
CALL
Autoliv
ALV
$9.02B
-10,000
Closed -$978K
AMD icon
4784
CALL
Advanced Micro Devices
AMD
$746B
-500,300
Closed -$47M
AMN icon
4785
AMN Healthcare
AMN
$1.34B
-40,204
Closed -$3.9M
AMP icon
4786
Ameriprise Financial
AMP
$49.6B
-2,652
Closed -$660K
AMPH icon
4787
Amphastar Pharmaceuticals
AMPH
$915M
-35,699
Closed -$720K
APAM icon
4788
Artisan Partners
APAM
$3.05B
-68,016
Closed -$3.46M
APG icon
4789
APi Group
APG
$17.6B
-18,089
Closed -$252K
APH icon
4790
Amphenol
APH
$192B
-1,125,764
Closed -$38.5M
API
4791
PUT
Agora
API
$358M
-17,800
Closed -$747K
APOG icon
4792
Apogee Enterprises
APOG
$863M
-8,118
Closed -$331K
AQB icon
4793
AquaBounty Technologies
AQB
$6.74M
-2,483
Closed -$266K
ARES icon
4794
Ares Management
ARES
$31.6B
-6,673
Closed -$424K
ARI
4795
Apollo Commercial Real Estate
ARI
$883M
-19,288
Closed -$308K
ARKK icon
4796
ARK Innovation ETF
ARKK
$6.41B
-14,542
Closed -$1.9M
ARMK icon
4797
Aramark
ARMK
$15.6B
-13,986
Closed -$376K
ARR
4798
Armour Residential REIT
ARR
$2.32B
-31,043
Closed -$1.68M
ASH icon
4799
Ashland
ASH
$3.38B
-52,569
Closed -$4.6M
ASYS icon
4800
Amtech Systems
ASYS
$245M
-24,958
Closed -$241K

Similar funds

David Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, David Shaw opened a new position in Sea Limited worth $206M.

  • David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • David Shaw opened 915 new positions and closed 695 in Q3 2021.
  • David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.